Bridging the gap between affordability and treatment

As pharmaceutical companies spend millions on research and development for cancer treatment, drugs can come with a hefty price tag. — Bloomberg

Advances in cancer treatment and rare disease have enabled patients to live longer.

However, the incredibly high research and development cost of these therapies often makes them unaffordable, even for those with personal health insurance.